In a wide-ranging Q&A, Proscia Co-founder and Chief Product Officer Nathan Buchbinder outlines why digital pathology adoption will be aided by a new set of CPT codes, and how it is already proving beneficial to diagnostics laboratories just a few years after its first FDA approval.
Featured Story:
Latest Articles
March 5, 2024
February 27, 2024